2026-04-17T03:11:38Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1835902025-12-05T13:10:48Zcom_2072_1057col_2072_478798col_2072_478917

Extra-anatomic aortic bypass for the treatment of a mycotic pseudoaneurysm after liver transplantation for hilar cholangiocarcinoma Lladó Garriga, Laura Iborra Ortega, Elena Ramos Rubio, Emilio Sabé, Nuria Cachero, Alba Fabregat Prous, Joan Arteritis Càncer de fetge Trasplantament hepàtic Derivació cardiopulmonar Arteritis Liver cancer Hepatic transplantation Cardiopulmonary bypass Liver transplantation (LT) after neoadjuvant chemoradiotherapy in patients with unresectable hilar cholangiocarcinoma (HC) is an accepted treatment strategy [1]. Neoadjuvant therapy is associated with an increased risk of arterial and portal complications after LT [1,2]. In most cases, radiation therapy makes the use of the native hepatic artery inadvisable, and an aortic anastomosis is needed, either with or without a graft [2]. The development of a mycotic pseudoaneurysm after LT is a rare complication that is associated with a high incidence of graft failure and mortality. Radiotherapy, local infections and the use of grafts are known risk factors for the development of a mycotic pseudoaneurysm, which is always challenging to manage [3]. 2022-02-28T17:13:11Z 2022-02-28T17:13:11Z 2020-09-01 2022-02-28T17:13:11Z info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion Versió postprint del document publicat a: https://doi.org/10.1016/j.hbpd.2020.08.009 Hepatobiliary & Pancreatic Diseases International, 2020, vol. 20, num. 3, p. 285-287 https://doi.org/10.1016/j.hbpd.2020.08.009 cc-by-nc-nd (c) Elsevier B.V., 2020 https://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess Elsevier B.V. Articles publicats en revistes (Ciències Clíniques)